Assignee
IDENIX PHARMACEUTICALS INC
US·53 granted patents·22 pending applications·3,101 citations·filing 1999–2015
Top patents by PatentIndex Score
75 records- 0199US7608600B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Oct 27, 2009·181 cites·85 claims
- 0299US7608597B2Methods and compositions for treating hepatitis C virusIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Oct 27, 2009·184 cites·33 claims
- 0399US7365057B2Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Apr 29, 2008·118 cites·52 claims
- 0499US6914054B2Methods and compositions for treating hepatitis C virusIDENIX PHARMACEUTICALS INC·Filed 2001·Granted Jul 5, 2005·252 cites·27 claims
- 0599US6812219B2Methods and compositions for treating flaviviruses and pestivirusesIDENIX PHARMACEUTICALS INC·Filed 2001·Granted Nov 2, 2004·211 cites·32 claims
- 0698US9211300B24′-fluoro nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Dec 15, 2015·66 cites·23 claims
- 0798US8507460B2Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Aug 13, 2013·67 cites·20 claims
- 0898US8343937B2Methods and compositions for treating flaviviruses and pestivirusesIDENIX PHARMACEUTICALS INC·Filed 2006·Granted Jan 1, 2013·52 cites·10 claims
- 0998US7635689B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Dec 22, 2009·120 cites·29 claims
- 1098US7582618B22′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2006·Granted Sep 1, 2009·81 cites·36 claims
- 1198US7547704B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Jun 16, 2009·84 cites·40 claims
- 1298US6566344B1β-L-2′-deoxy-nucleosides for the treatment of hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2001·Granted May 20, 2003·122 cites·105 claims
- 1397US9187515B22′,4′-fluoro nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Nov 17, 2015·51 cites·16 claims
- 1497US7951789B2Compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2007·Granted May 31, 2011·92 cites·10 claims
- 1597US7902202B2Compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2008·Granted Mar 8, 2011·80 cites·29 claims
- 1697US7625875B22′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Dec 1, 2009·86 cites·44 claims
- 1797US7384924B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Jun 10, 2008·77 cites·46 claims
- 1897US6875751B23′-prodrugs of 2′-deoxy-β-L-nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2001·Granted Apr 5, 2005·131 cites·25 claims
- 1997US6787526B1Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2002·Granted Sep 7, 2004·93 cites·25 claims
- 2097US6569837B1β-L-2′-deoxy pyrimidine nucleosides for the treatment of hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2001·Granted May 27, 2003·98 cites·49 claims
- 2196US9309275B23′-deoxy nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Apr 12, 2016·28 cites·24 claims
- 2296US9109001B23′,5′-cyclic phosphoramidate prodrugs for HCV infectionIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Aug 18, 2015·60 cites·28 claims
- 2396US7662798B22′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Feb 16, 2010·77 cites·20 claims
- 2496US7456155B22′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Nov 25, 2008·88 cites·39 claims
- 2595US8362068B25,5-fused arylene or heteroarylene hepatitis C virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·66 cites·53 claims
- 2695US6596700B2Methods of treating hepatitis delta virus infection with β-L-2'-deoxy-nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2001·Granted Jul 22, 2003·61 cites·57 claims
- 2794US9296778B23′,5′-cyclic phosphate prodrugs for HCV infectionIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·37 cites·21 claims
- 2894US7932240B2Phosphadiazine HCV polymerase inhibitors IVIDENIX PHARMACEUTICALS INC·Filed 2008·Granted Apr 26, 2011·39 cites·61 claims
- 2994US7585851B23′-prodrugs of 2′-deoxy-β-L-nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Sep 8, 2009·69 cites·112 claims
- 3093US9339541B2Thiophosphate nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted May 17, 2016·36 cites·20 claims
- 3192US7824851B22′-branched nucleosides and Flaviviridae mutationIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Nov 2, 2010·75 cites·27 claims
- 3291US7781576B2Process for preparing a synthetic intermediate for preparation of branched nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2006·Granted Aug 24, 2010·29 cites·38 claims
- 3390US7534809B2Phospho-indoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2005·Granted May 19, 2009·16 cites·82 claims
- 3489US7304043B2β-L-2′-deoxy-nucleosides for the treatment of hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2005·Granted Dec 4, 2007·8 cites·24 claims
- 3588US9249173B2Compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·8 cites·23 claims
- 3688US8481748B2Phosphinate ruthenium complexesIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Jul 9, 2013·4 cites·42 claims
- 3787US9186369B2Purine nucleoside analogues for treating flaviviridae including hepatitis CIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Nov 17, 2015·8 cites·28 claims
- 3887US8377962B2Macrocyclic serine protease inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2010·Granted Feb 19, 2013·14 cites·93 claims
- 3987US7598373B2Process for the production of 2-C-methyl-D-ribonolactoneIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Oct 6, 2009·43 cites·30 claims
- 4087US6710068B2Phenylindoles for the treatment of HIVIDENIX PHARMACEUTICALS INC·Filed 2002·Granted Mar 23, 2004·25 cites·14 claims
- 4184US9187496B25,5-fused arylene or heteroarylene hepatitis C virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Nov 17, 2015·8 cites·45 claims
- 4284US8993595B2Macrocyclic serine protease inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Mar 31, 2015·8 cites·96 claims
- 4384US7795238B2β-L-2′-deoxy-nucleosides for the treatment of hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2007·Granted Sep 14, 2010·3 cites·18 claims
- 4483US8765966B2Phosphinate ruthenium complexesIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Jul 1, 2014·2 cites·42 claims
- 4582US7186700B2β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapiesIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Mar 6, 2007·18 cites·24 claims
- 4680US2011195922A9Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4779US7960428B2Enantiomerically pure phosphoindoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2007·Granted Jun 14, 2011·3 cites·42 claims
- 4876US8410313B2Phosphinate ruthenium complexesIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Apr 2, 2013·1 cites·20 claims
- 4976US8044091B2Phospho-indoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2008·Granted Oct 25, 2011·2 cites·25 claims
- 5075US2014213540A1Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when IDENIX PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →